$244.94
1.960.81%
At Close: -
$244.94
00.00%
After Hours: Sep 20, 4:39 PM EDT
15 minutes delayed
ResMed reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ResMed using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $2.08 | $2.06 | 0.97 % |
Mar 2024 | 2024-04-25 | $2.13 | $1.91 | 11.5 % |
Dec 2023 | 2024-01-24 | $1.88 | $1.79 | 5.03 % |
Sep 2023 | 2023-10-26 | $1.64 | $1.62 | 1.23 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $1.22B | $1.19B | 2.77 % |
Mar 2024 | 2024-04-25 | $1.20B | $1.17B | 2.31 % |
Dec 2023 | 2024-01-24 | $1.16B | $1.15B | 1.13 % |
Sep 2023 | 2023-10-26 | $1.10B | $1.10B | 0.18 % |
ResMed (RMD) is scheduled to report earnings on October 24, 2024. The last reported earnings were for reported on August 1, 2024 for Q4.
The Actual EPS was $2.08, which beat the estimate of $2.06.
The Actual Revenue was $1.2B, which beat the estimate of $1.2B.
Browse earnings estimates, EPS, and revenue on all stocks.